Idera Home Page
Home| Site Map| Contact| Careers
    • Letter to Shareholders
    • Management Team
    • Board of Directors
    • Advisory Boards
    • Corporate Governance
    • Careers
    • Oncology
    • Infectious Diseases
    • Autoimmune Diseases
    • Respiratory Diseases
    • Vaccine Adjuvants
    • Agonists
    • Antagonists
    • Scientific Publications
    • Intellectual Property
    • Novartis International Pharmaceutical, Ltd.
    • Merck & Co., Inc.
    • Merck KGaA
    • Overview
    • Corporate Governance
    • Stock Information
    • Financial Reports
    • SEC Filings
    • Event Calender
    • Webcasts
    • Presentations
    • News
    • FAQ
    • Analyst Coverage
    • Information Request
    • E-mail Alerts
    • Investor Contact
    About Idera
  • Letter to Stockholders
  • Management Team
  • Board of Directors
  • Advisory Boards
  • Corporate Governance
  • Careers
About Idera » Management Team

Management Team

Sudhir Agrawal, D. Phil. ׀ Chief Executive Officer and Chief Scientific Officer
Lou Arcudi ׀ Chief Financial Officer, Treasurer and Secretary
Alice S. Bexon, MBChB. ׀ Vice President, Clinical Development
Timothy M. Sullivan, Ph.D. ׀ Vice President, Development Programs
Ekambar R. Kandimalla, Ph.D. ׀ Vice President, Discovery
Steven J. Ritter, Ph.D., J.D. ׀ Vice President, Intellectual Property and Contracts
David M. Lough, Ph.D. ׀ Director, Business Development and Alliance Management
Frank Whalen, C.P.A. ׀ Controller


Idera Pharmaceuticals, Inc., ©2008 - All Rights Reserved. Terms of Use
About Idera| Pipeline| TLR Technology| Partners| Investors| Collaborators| Site Map| Contact| Careers